Previous Article | Next Article ![]()
Journal of Virology, August 2000, p. 6748-6759, Vol. 74, No. 15
Beirne B. Carter Center for Immunology
Research1 and Departments of
Pathology2 and
Microbiology,3 University of
Virginia Health Sciences Center, Charlottesville, Virginia 22908
Received 15 December 1999/Accepted 3 May 2000
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that
persistently infects 85% of the adult population worldwide. In this
report, we examine the proliferative response and cytokine secretion
profile of CD4+ T lymphocytes from a panel of unrelated
EBV-positive donors against two EBV latent antigens, EBNA1 and EBNA3C.
Substantial proliferative responses by CD4+ lymphocytes
were demonstrated to both antigens in multiple, randomly selected
donors. Surprisingly, we observed a striking and consistent difference
in cytokine response to EBNA1 and EBNA3C. EBNA1-specific CD4+ T lymphocytes from multiple unrelated donors
preferentially produced type 2-like cytokines in response to antigenic
stimulation, while the response to EBNA3C was a characteristic type 1 response. The implications of these findings for EBV persistence and
the development of EBV-associated malignancies are discussed.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Type 2 Cytokines Predominate in the Human CD4+
T-Lymphocyte Response to Epstein-Barr Virus Nuclear Antigen 1
*
Corresponding author. Mailing address: Beirne Carter
Center for Immunology Research, P.O. Box 801386, 400 Lane Road, MR-4 Building, Rm. 4012, University of Virginia, Charlottesville, VA 22908. Phone: (804) 924-1219. Fax: (804) 924-1221. E-mail:
tjb2r{at}virginia.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|